Matrine
inhibits microglial ferroptosis and reduces inflammation
12 lab studies · helped in 100%
152
Treatments tested only in the lab
74
Genes linked to MS that no trial has targeted
2,710
Lab studies since 2015
MOST STUDIED
inhibits microglial ferroptosis and reduces inflammation
12 lab studies · helped in 100%
inhibits autophagy, reducing mitochondrial clearance and improving myelination
7 lab studies · helped in 100%
Blocks NLRP3 inflammasome, curbing glial activation, M1 microglia
6 lab studies · helped in 100%
Activates Nrf2/HO-1 antioxidant and blocks TLR4/NF-κB inflammation
6 lab studies · helped in 100%
Blocks CSF1R, reducing microglia and increasing oligodendrocytes
5 lab studies · helped in 60%
Supplies phosphatidylcholine precursor for myelin membrane regeneration
2 lab studies · helped in 100%
reduces oxidative stress and protects cerebellar tissue
3 lab studies · helped in 100%
Replaces oligodendrocytes, boosts myelin genes, lowers CSPG levels
2 lab studies · helped in 100%
enhances remyelination in microglia-containing organoids
2 lab studies · helped in 100%
inhibits histone deacetylases and boosts antioxidant response
2 lab studies · helped in 100%
GENES
Human genetic studies link these genes to the risk of MS. No trial in the Trial Bank has tested a medicine acting on them yet.
EARLIER SUCCESSES
Of the approaches that helped in most lab studies and were then tested in people, 11 were confirmed and 10 failed. See From animals to people →
EVERYTHING